Drug Design, Development and Therapy

eISSN: 1177-8881pISSN: 1177-8881
JournalOpen Access

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Aims and Scope

Drug Design, Development and Therapy is a peer-reviewed medical journal covering research on drug design and development through to clinical applications. The journal was established in 2007 and is published by Dove Medical Press. Less

Key Metrics

CiteScore
6.6
Eigenfactor
0.01 - 0.05
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
1.12
4
Time to Publish
time-to-publish View Chart
4  Mo

Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
  • Publisher
    DOVE MEDICAL PRESS LTD
  • Language
    English
  • Frequency
    Continuous publication
  • Article Processing Charges
    USD 2836
  • Publication Time
    16
  • Editorial Review Process
    Anonymous peer review
General Details
Publication Details
Editorial Review Detail
Information for authors
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 20%
4-6 71%
7-9 9%
>9 0%

Topics Covered

Cancer
Oxidative stress
Lidocaine
Toxicity
Clinical trial
Anti-inflammatory
Myocardial infarction
Reactive oxygen species
Dexamethasone
Western blot
Quercetin
Superoxide dismutase
Autophagy
Lung
Hepatocellular carcinoma
Curcumin
Osteoporosis
Femoral head
Xanthone
Lung cancer

Recently Published Papers

FAQs

Since when has Drug Design, Development and Therapy been publishing? Faqs

The Drug Design, Development and Therapy has been publishing since 2007 till date.

How frequently is the Drug Design, Development and Therapy published? Faqs

Drug Design, Development and Therapy is published Continuous publication.

Who is the publisher of Drug Design, Development and Therapy? Faqs

The publisher of Drug Design, Development and Therapy is DOVE MEDICAL PRESS LTD.

Where can I find a journal's aims and scope of Drug Design, Development and Therapy? Faqs

For the Drug Design, Development and Therapy's Aims and Scope, please refer to the section above on the page.

How can I view the journal metrics of Drug Design, Development and Therapy on editage? Faqs

For the Drug Design, Development and Therapy metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Drug Design, Development and Therapy? Faqs

The eISSN number is 1177-8881 and pISSN number is 1177-8881 for Drug Design, Development and Therapy.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Cancer, Oxidative stress, Lidocaine, Toxicity, Clinical trial, Anti-inflammatory, Myocardial infarction, Reactive oxygen species, Dexamethasone, Western blot, Quercetin, Superoxide dismutase, Autophagy, Lung, Hepatocellular carcinoma, Curcumin, Osteoporosis, Femoral head, Xanthone, Lung cancer.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.